Search Results 1181-1190 of 21678 for Inhibition

  1. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

    For CLL/SLL, patients must have received prior therapies, namely a BTK inhibitor or BCL-2 inhibitor. These patients may or may not have received prior ...

  2. The International Diabetes Closed Loop Trial DCLP4 - Mayo Clinic

    Use of Afrezza or any non-insulin glucose-lowering agent other than metformin (including GLP-1 agonists, DPP-4 inhibitors, SGLT-2 inhibitors, sulfonylureas) ...

  3. Iga Nephropathy Clinical Trials - Mayo Clinic Research

    ... inhibitors and angiotensin receptor blockers (ARBs). These patients are at high risk for progression of kidney disease, which can result in end-stage renal ...

  4. A Safety Study of SGN-CD19A for Leukemia and Lymphoma - Mayo Clinic

    Patients with acute lymphoblastic leukemia who are Philadelphia chromosome-positive must have failed a second generation tyrosine kinase inhibitor. Eastern ...

  5. Alzheimer's Disease Neuroimaging Initiative 4 - Mayo Clinic

    Cholinesterase inhibitors and memantine are allowable if stable for 12 weeks prior to screen; 6. Aducanumab and any other approved treatments for the ...

  6. A Study to Evaluate the Safety of Lasofoxifene in Combination with Abemaciclib in Advanced or Metastatic ER+/HER2− Breast Cancer with ESR1 Mutation - Mayo Clinic

    Progression may have occurred on no more than 2 of the following endocrine treatments for metastatic breast cancer: an aromatase inhibitor (AI) and/or ...

  7. Video Transcript - Spontaneous Coronary Artery Dissection (SCAD) Research Program

    Some have heard questions specifically about whether patients should continue taking angiotensin-converting enzyme (ACE) inhibitors or angiotensin II ...

  8. A Study To Evaluate The Effects Of Oral Levosimendan (ODM-109) On Respiratory Function In Patients With ALS - Mayo Clinic

    ... inhibition of ovulation, intrauterine devices and long acting progestin agents), if sexually active during the study, and for 1 month after the last dose of ...

  9. A Study of Gemcitabine-Cisplatin Chemotherapy plus Necitumumab in the First-Line Treatment of Patients with Lung Cancer - Mayo Clinic

    Prior anticancer therapy with monoclonal antibodies, signal transduction inhibitors, or any therapies targeting the epidermal growth factor receptor (EGFR), ...

  10. Investigational Extended Wear Insulin Infusion Set During Home Use for Type 1 Diabetes - Mayo Clinic

    Concurrent use of any non-insulin glucose-lowering agent, other than metformin (for example, GLP-1 agonists, Symlin, DPP-4 inhibitors, SGLT-2 inhibitors, ...